in the 37 patients who completed the trial there was no significant difference between propranolol 160 mg and femoxetine 400 mg with respect to the number of headache days or the number of migraine attacks during the last 2 months of each treatment , propranolol , however , was superior to femoxetine when the headache index was used ( p less than 0.05 ) .
C0149931
migraine
C0018681
headache